1. Home
  2. NTRA
  3. NTRA News

Latest Natera Inc. (NTRA) News on March 29, 2025

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting
NTRA

Business Wire

4 days ago

DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?
NTRA

Insider Monkey

5 days ago

Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now?

Here’s What Lifted Natera (NTRA) in Q4 and 2024
NTRA

Insider Monkey

9 days ago

Here’s What Lifted Natera (NTRA) in Q4 and 2024

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack
NTRA

StockStory

9 days ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?
NTRA

Insider Monkey

11 days ago

Is Natera (NTRA) the Best Biotech Stock According to Billionaires?

NTRA

Argus Research

12 days ago

Daily – Vickers Top Buyers & Sellers for 03/17/2025

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value
NTRA

Simply Wall St.

15 days ago

Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value

Exploring Three High Growth Tech Stocks In The US Market
NTRA

Simply Wall St.

15 days ago

Exploring Three High Growth Tech Stocks In The US Market

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board
NTRA

Simply Wall St.

16 days ago

Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board

Why Is Natera (NTRA) Stock Soaring Today
NTRA

StockStory

18 days ago

Why Is Natera (NTRA) Stock Soaring Today

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
NTRA

Business Wire

19 days ago

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say
NTRA

Zacks

22 days ago

Natera (NTRA) Reports Q4 Earnings: What Key Metrics Have to Say

NTRA

MT Newswires

24 days ago

Natera Set to Continue Upside Surprises During 2025, Beyond, Morgan Stanley Says

NTRA

MT Newswires

25 days ago

Natera Granted US Patent for Testing Single Nucleotide Variants

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD
NTRA

Business Wire

25 days ago

Natera Expands Intellectual Property Portfolio With New Patents in Tumor-Informed MRD

Natera Full Year 2024 Earnings: Beats Expectations
NTRA

Simply Wall St.

25 days ago

Natera Full Year 2024 Earnings: Beats Expectations

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
NTRA

Simply Wall St.

a month ago

Earnings Update: Natera, Inc. (NASDAQ:NTRA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

NTRA

Thomson Reuters StreetEvents

a month ago

Q4 2024 Natera Inc Earnings Call

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements
NTRA

GuruFocus.com

a month ago

Natera Inc (NTRA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates
NTRA

Zacks

a month ago

Natera (NTRA) Reports Q4 Loss, Tops Revenue Estimates

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
NTRA

StockStory

a month ago

Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales

Natera Reports Fourth Quarter and Full Year 2024 Financial Results
NTRA

Business Wire

a month ago

Natera Reports Fourth Quarter and Full Year 2024 Financial Results

Natera (NTRA) Q4 Earnings: What To Expect
NTRA

StockStory

a month ago

Natera (NTRA) Q4 Earnings: What To Expect

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect
NTRA

GuruFocus.com

a month ago

Natera Inc (NTRA) Q4 2024 Earnings Report Preview: What To Expect

NTRA

MT Newswires

a month ago

Natera's Signatera Lung Cancer Test Meets Medicare Coverage Requirements

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
NTRA

Business Wire

a month ago

Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio
NTRA

Insider Monkey

a month ago

Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio

Natera (NTRA) Surged on Blowout Quarterly Results
NTRA

Insider Monkey

a month ago

Natera (NTRA) Surged on Blowout Quarterly Results

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
NTRA

Business Wire

a month ago

Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025

Schrodinger Stock Scores IBD Rating Upgrade
NTRA

Investor's Business Daily

a month ago

Schrodinger Stock Scores IBD Rating Upgrade

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
NTRA

Business Wire

2 months ago

NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma

High Growth Tech Stocks to Watch in February 2025
NTRA

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in February 2025

Natera Announces National Commercial Coverage for its Fetal RhD NIPT
NTRA

Business Wire

2 months ago

Natera Announces National Commercial Coverage for its Fetal RhD NIPT

Here’s Why Natera (NTRA) Surged in Q4
NTRA

Insider Monkey

2 months ago

Here’s Why Natera (NTRA) Surged in Q4

Natera reports new data from Phase III study of colorectal cancer detection test
NTRA

Medical Device Network

2 months ago

Natera reports new data from Phase III study of colorectal cancer detection test

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
NTRA

Business Wire

2 months ago

Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer

Natera to Present New Data at the 2025 ASCO GI Symposium
NTRA

Business Wire

2 months ago

Natera to Present New Data at the 2025 ASCO GI Symposium

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
NTRA

Investor's Business Daily

2 months ago

Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
NTRA

Business Wire

2 months ago

Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'
NTRA

Investor's Business Daily

2 months ago

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection
NTRA

Business Wire

2 months ago

Natera Announces Innovation Roadmap, with Advancements in MRD and Early Cancer Detection

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024
NTRA

Business Wire

3 months ago

Natera Announces Preliminary Fourth Quarter and Full-Year Results for 2024

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings
NTRA

Motley Fool

3 months ago

Here Are Billionaire Stanley Druckenmiller's 5 Biggest Stock Holdings

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
NTRA

Business Wire

3 months ago

Natera to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Six IBD 50 Stocks Bear Gifts Even As Santa Claus Rally Fizzles
NTRA

Investor's Business Daily

3 months ago

Six IBD 50 Stocks Bear Gifts Even As Santa Claus Rally Fizzles

High Growth Tech Stocks To Watch In January 2025
NTRA

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In January 2025

3 US Stocks That May Be Trading At A Discount
NTRA

Simply Wall St.

3 months ago

3 US Stocks That May Be Trading At A Discount

Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years
NTRA

Simply Wall St.

3 months ago

Natera's (NASDAQ:NTRA) investors will be pleased with their enviable 353% return over the last five years

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?
NTRA

Zacks

3 months ago

Natera (NTRA) Just Flashed Golden Cross Signal: Do You Buy?

NTRA

MT Newswires

3 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics
NTRA

Business Wire

3 months ago

Court Grants Natera’s Request to Include Additional Patent in its Lawsuit Against NeoGenomics

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?
NTRA

Insider Monkey

3 months ago

What Makes Natera (NTRA) a Top Stock Pick for Billionaire Stanley Druckenmiller?

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer
NTRA

TipRanks

4 months ago

Natera enrolls 1st patients in SAGITTARIUS clinical trial in colon cancer

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer
NTRA

Business Wire

4 months ago

Natera Announces Enrollment of First Patients in SAGITTARIUS: a Randomized, Phase III Clinical Trial in Colon Cancer

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment
NTRA

Business Wire

4 months ago

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment

Strong Volume Growth Lifted Natera (NTRA) in Q3
NTRA

Insider Monkey

4 months ago

Strong Volume Growth Lifted Natera (NTRA) in Q3

Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?
NTRA

Insider Monkey

4 months ago

Why Is Natera, Inc. (NTRA) Among the Best High Growth Healthcare Stocks to Invest In Now?

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology
NTRA

Business Wire

4 months ago

Clinical Validation Study on Natera’s Fetal RhD NIPT Published in Obstetrics & Gynecology

Guardant awarded nearly $293M in false ad trial against Natera
NTRA

MedTech Dive

4 months ago

Guardant awarded nearly $293M in false ad trial against Natera

Exploring Three High Growth Tech Stocks In The United States
NTRA

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks In The United States

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients
NTRA

Business Wire

4 months ago

Natera Announces Medicare Coverage for Prospera™ in Single Lung Transplant Recipients

NTRA

MT Newswires

4 months ago

Guardant Health Wins False Advertising Suit Against Natera

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium
NTRA

Business Wire

4 months ago

Natera to Present New SignateraTM Data in Multiple Abstracts at the San Antonio Breast Cancer Symposium

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
NTRA

PR Newswire

4 months ago

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

Natera Issues Statement on Guardant Health Litigation
NTRA

Business Wire

4 months ago

Natera Issues Statement on Guardant Health Litigation

Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
NTRA

Business Wire

4 months ago

Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM
NTRA

Business Wire

4 months ago

Natera Announces Publication of over 100 Peer-Reviewed Papers on SignateraTM

Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets
NTRA

Simply Wall St.

4 months ago

Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets

Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024
NTRA

GuruFocus.com

4 months ago

Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024

Natera Third Quarter 2024 Earnings: Beats Expectations
NTRA

Simply Wall St.

4 months ago

Natera Third Quarter 2024 Earnings: Beats Expectations

Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?
NTRA

GuruFocus.com

5 months ago

Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started?

Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...
NTRA

GuruFocus.com

5 months ago

Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ...

Decoding Natera Inc (NTRA): A Strategic SWOT Insight
NTRA

GuruFocus.com

5 months ago

Decoding Natera Inc (NTRA): A Strategic SWOT Insight

Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
NTRA

Zacks

5 months ago

Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates
NTRA

Zacks

5 months ago

Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates

NTRA

Associated Press Finance

5 months ago

Natera: Q3 Earnings Snapshot

Natera Reports Third Quarter 2024 Financial Results
NTRA

Business Wire

5 months ago

Natera Reports Third Quarter 2024 Financial Results

Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer
NTRA

Business Wire

5 months ago

Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer

Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect
NTRA

GuruFocus.com

5 months ago

Natera Inc (NTRA) Q3 2024 Earnings Report Preview: What To Expect

Natera to Participate in Upcoming Investor Conferences
NTRA

Business Wire

5 months ago

Natera to Participate in Upcoming Investor Conferences

Natera to Report its Third Quarter 2024 Results on November 12, 2024
NTRA

Business Wire

5 months ago

Natera to Report its Third Quarter 2024 Results on November 12, 2024

Exploring Three High Growth Tech Stocks in the United States
NTRA

Simply Wall St.

5 months ago

Exploring Three High Growth Tech Stocks in the United States

Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term
NTRA

Simply Wall St.

5 months ago

Loss-Making Natera, Inc. (NASDAQ:NTRA) Expected To Breakeven In The Medium-Term

All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy
NTRA

Zacks

5 months ago

All You Need to Know About Natera (NTRA) Rating Upgrade to Strong Buy

Natera to Present New Renasight Data at ASN Kidney Week 2024
NTRA

Business Wire

5 months ago

Natera to Present New Renasight Data at ASN Kidney Week 2024

Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now
NTRA

Insider Monkey

6 months ago

Natera Inc. (NTRA): Hedge Funds Are Bullish On This NASDAQ Stock Right Now

High Growth Tech Stocks To Watch In September 2024
NTRA

Simply Wall St.

6 months ago

High Growth Tech Stocks To Watch In September 2024

Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate
NTRA

Simply Wall St.

6 months ago

Natera, Inc. (NASDAQ:NTRA) Shares Could Be 23% Above Their Intrinsic Value Estimate

NTRA

MT Newswires

6 months ago

Update: Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

NTRA

MT Newswires

6 months ago

Natera Says Court Orders Permanent Injunction Against NeoGenomics' RaDaR Assay

Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
NTRA

Business Wire

6 months ago

Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase

Should You Be Confident in the Growth Potential of Natera (NTRA)?
NTRA

Insider Monkey

6 months ago

Should You Be Confident in the Growth Potential of Natera (NTRA)?

ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test
NTRA

Medical Device Network

6 months ago

ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test

Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO
NTRA

Business Wire

6 months ago

Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO

First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
NTRA

Business Wire

6 months ago

First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival

Natera (NTRA) Continued its Incremental Strong Results
NTRA

Insider Monkey

7 months ago

Natera (NTRA) Continued its Incremental Strong Results

DNA Testing Stock Taps AI Amid 85% Surge
NTRA

Investor's Business Daily

7 months ago

DNA Testing Stock Taps AI Amid 85% Surge

Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
NTRA

Business Wire

7 months ago

Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival

What Makes Natera (NTRA) an Investment Bet?
NTRA

Insider Monkey

7 months ago

What Makes Natera (NTRA) an Investment Bet?

Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates
NTRA

Insider Monkey

7 months ago

Natera (NTRA) Rose After Revenues And Profit Margins Beat Estimates

Share on Social Networks: